GlassScriptPhysician profile
Joseph El Youssef
NPI 1154445641
$2,571.60
in general payments reported to CMS, 2019-2025
14 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2023: $50.56 · 2024: $1,506 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.36 |
| Travel and Lodging | $960.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,426.15 | 2024-2025 | Minimed 780g |
| Dexcom, INC. | $253.13 | 2019-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $234.46 | 2023-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $223.22 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $130.60 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $94.56 | 2025 | Omnipod |
| Aimmune Therapeutics, INC. | $46.42 | 2025 | Zenpep |
| Averitas Pharma INC. | $40.61 | 2025 | Qutenza |
| Companion Medical, INC. | $36.54 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.63 | 2025 | Gvoke Hypopen |
| Kyowa Kirin, INC. | $18.95 | 2025 | |
| Sequel Med Tech, LLC | $17.20 | 2025 | Twiist |
| Alexion Pharmaceuticals, INC. | $17.00 | 2024 | Strensiq |
| Medtronic Minimed, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph El Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.